REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
22/09/2025
Voltar para busca
Dado oficial do USPTO
PLEXZYME
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
23/09/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42, 44
Data de depósito
17/06/2019
Data de registro
22/09/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/09/2020
Última transação
23/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
82
Localização do titular
EVELEIGH NSW 2015, AU
Examinador
MESSICK, TABITHA
Unidade examinadora
L40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
SpeeDx Pty Ltd
SpeeDx Pty Ltd
Representantes
Joi A. White Carr & Ferrell LLP
Classificação técnica
Classes Nice
Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Scientific and technological services and research and design relating theretoDNA analysis services for scientific research purposesscientific research consulting in the field of genetics; genetic research; genetic engineering services; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry serviceschemistry research services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of medical diagnostic apparatus; design of medical diagnostic apparatus; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biologicalbacteriologicalchemicalbiochemicalDNARNAproteinpolynucleic acid and molecular analysis and evaluation services for scientific testing and research purposes; DNA and RNA and polynucleic acid and protein sequencinganalysis and evaluation services for scientific testing and research purposes; genome sequencing services and the analysis and evaluation of data resulting therefrom for scientific testing and research purposes; scientific analysis and the provision of reports in conjunction therewith relating to scientific and medical experimentsrelating to the results of scientific and medical experiments and testsrelating to the analysis and evaluation of scientific and medical datarelating to data generated by scientific and medical experiments and tests; scientific and medical research and development services; custom design and development of biochemical assays
Classe 44
Medical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services relating to DNAgenetics and genetic testing; medical diagnostic services in the nature of medical testing and medical analysis; molecular diagnostics testing for medical purposes; providing collected and analysed medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; medical diagnostic imaging and molecular medicine services
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/08/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/04/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
16/03/2021
FIMP
FINAL DISPOSITION PROCESSED
16/03/2021
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
16/03/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
22/12/2020
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
10/10/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
22/09/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/07/2020
PUBO
PUBLISHED FOR OPPOSITION
07/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/06/2020
ALIE
ASSIGNED TO LIE
04/06/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/05/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/05/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/05/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/05/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19/12/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19/12/2019
RFNT
REFUSAL PROCESSED BY IB
06/12/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
18/11/2019
RFRR
REFUSAL PROCESSED BY MPU
18/11/2019
MAFR
APPLICATION FILING RECEIPT MAILED
29/10/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
27/10/2019
CNRT
NON-FINAL ACTION WRITTEN
26/10/2019
DOCK
ASSIGNED TO EXAMINER
25/10/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/10/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
24/10/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PLEXZYME ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.